Europe T Cell Therapy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe T Cell Therapy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe T Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe T Cell Therapy Market Regional Analysis

6.2 Europe T Cell Therapy Market Revenue 2020-2030 (US$ Million)

6.3 Europe T Cell Therapy Market Forecast Analysis

7. Europe T Cell Therapy Market Analysis – by Modality

7.1 Research

7.1.1 Overview
7.1.2 Research: Europe T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Commercialized

7.2.1 Overview
7.2.2 Commercialized: Europe T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe T Cell Therapy Market Analysis – by Therapy Type

8.1 CAR T-cell Therapy

8.1.1 Overview
8.1.2 CAR T-cell Therapy: Europe T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 T-cell Receptor-based

8.2.1 Overview
8.2.2 T-cell Receptor-based: Europe T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe T Cell Therapy Market Analysis – by Indication

9.1 Hematologic Malignancies

9.1.1 Overview
9.1.2 Hematologic Malignancies: Europe T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Solid Tumors

9.2.1 Overview
9.2.2 Solid Tumors : Europe T Cell Therapy Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe T Cell Therapy Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe T Cell Therapy Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Europe T Cell Therapy Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 UK: Europe T Cell Therapy Market Breakdown, by Modality
10.2.1.1.2 UK: Europe T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.1.3 UK: Europe T Cell Therapy Market Breakdown, by Indication

10.2.1.2 Germany: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 Germany: Europe T Cell Therapy Market Breakdown, by Modality
10.2.1.2.2 Germany: Europe T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.2.3 Germany: Europe T Cell Therapy Market Breakdown, by Indication

10.2.1.3 France: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 France: Europe T Cell Therapy Market Breakdown, by Modality
10.2.1.3.2 France: Europe T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.3.3 France: Europe T Cell Therapy Market Breakdown, by Indication

10.2.1.4 Russia: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Russia: Europe T Cell Therapy Market Breakdown, by Modality
10.2.1.4.2 Russia: Europe T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.4.3 Russia: Europe T Cell Therapy Market Breakdown, by Indication

10.2.1.5 Italy: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Italy: Europe T Cell Therapy Market Breakdown, by Modality
10.2.1.5.2 Italy: Europe T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.5.3 Italy: Europe T Cell Therapy Market Breakdown, by Indication

10.2.1.6 Rest of Europe: Europe T Cell Therapy Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe T Cell Therapy Market Breakdown, by Modality
10.2.1.6.2 Rest of Europe: Europe T Cell Therapy Market Breakdown, by Therapy Type
10.2.1.6.3 Rest of Europe: Europe T Cell Therapy Market Breakdown, by Indication

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Bristol-Myers Squibb Co

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Gilead Sciences Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Immunocore Holdings Plc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Innovent Biologics Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Janssen Global Services LLC

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Legend Biotech Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Novartis AG

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe T Cell Therapy Market

Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)